Background Factors early after stroke that are predictive of outcomes can help guide rehabilitation interventions. There is a growing understanding of the importance of sleep for recovery after stroke.

Objectives To explore factors at 10 days post stroke, including sleep health (SH), that may be associated with QOL at 60 days post stroke.

Methods Data from 62 participants were collected at 10 and 60 days post stroke. Independent variables at 10 days post stroke were the NIHSS, Barthel Index (BI), Montreal Cognitive Assessment (MOCA), Patient Health Questionnaire (PHQ-9), gait speed, Berg Balance Scale, and SH. SH was measured by combining data from actigraphy and self-report to create a score that reflected regularity, satisfaction, alertness, timing, efficiency, and duration of sleep (S-Ru-SATED). The Stroke Impact Scale (SIS) at 60 days post stroke assessed quality of life. A multiple linear regression using a leave-one-out cross validation was employed to assess the association between the independent variables at 10 days and the SIS at 60 days.

Results The leave-one-out cross-validation analysis revealed that MOCA (p=0.0068), NIHSS (p=0.0181), BI (p=0.0028), and S-Ru-SATED (p=0.000155) at 10 days post stroke were significantly associated with the SIS at 60 days post stroke.

Conclusions Participants with less stroke severity, higher cognition, better functional ability, and better SH early after stroke were more likely to have a higher QOL at 2 months post stroke. Research is needed to assess the impact of interventions to improve SH in conjunction with rehabilitation interventions after stroke.

The authors have declared no competing interest.

This work was funded by the National Institutes of Health NINR, Award Number R01NR018979

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This research was approved by the following Institutional Review Boards: WCG IRB, Upstate Medical University IRB, University of Kansas Medical Center IRB, and Emory University IRB.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All authors have reviewed and approved the manuscript

Data Availability Statement: the data are not available at this time

Funding Support: This work was supported by the National Institutes of Health NINR, Award Number R01NR018979

Conflict of Interest: The authors report there are no competing interests to declare.

Clinical Trial Number: NCT05012605

Data produced for this study are not currently available.